Avoidant/Restrictive Food Intake Disorder (ARFID) ARFID involves a severe pattern of avoiding certain foods or selective eating that results in failure to meet nutritional needs without the body shape or body weight concerns central to anorexia nervosa
GLP-1 agonists and blood pressure: a review of the evidence
3 "These phase 2 data have given us confidence to further explore the potential of retatrutide in phase 3 trials that will look beyond weight reduction and focus on treating obesity and its complications comprehensively." The companys TRIUMPH phase 3 development program will evaluate the safety and efficacy of retatrutide for chronic weight management, obstructive sleep apnea, and knee osteoarthritis in people with obesity and overweight
With advances in telehealth and AI, patients now have unprecedented access to reliable medical information and personalized care
So going back to the subtopic of microdosing, I think generally you and I are talking about the same thing when we just start talking about a lower than one milligram per week or 2.5mg per week dose
Other drugs in the Ozempic MDL The other drugs involved in the MDL lawsuits currently include Rybelsus , Wegovy , Mounjaro and Trulicity